Opinion
Video
Mirna Chehade, MD, MPH, emphasizes the value of proton pump inhibitors, swallowed corticosteroids, and dietary restrictions as therapeutic options for pediatric patients with eosinophilic esophagitis (EoE), while underscoring the importance of shared decision-making to maintain adherence and achieve better outcomes.
This is a video synopsis/summary of an Insights involving Mirna Chehade, MD, MPH.
Chehade explores the role of proton pump inhibitors and oral glucocorticoids in treating pediatric eosinophilic esophagitis (EoE), emphasizing their necessity for long-term management. Treatment sequencing involves shared decision-making with parents and older children, ensuring better outcomes and adherence. Nonpharmacological options, such as dietary restriction therapies, require careful consideration based on factors like age, nutritional status, and social/financial support. Acceptance of multiple endoscopies is crucial for identifying trigger foods in remission. The discussion underscores the need for an individualized approach, balancing pharmacological and nonpharmacological options through effective shared decision-making in pediatric EoE treatment.
Video synopsis is AI-generated and reviewed by AJMC® editorial staff.
2 Commerce Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.